is that all about. AAPL should be over 130 right now. Total BS
on 3/12 BofA/Merrill reiterated SWKS with a buy and a share price target of $110.00. It is not too late to get in. SWKS has their hands in the fastest growing areas of the economy. Long and strong SWKS.
ACAD must be having some excellent data being conveyed. Long and strong ACAD. Onward and upward to $50 and beyond.
in the low 90's with more to buy if it goes lower.
someone wants in at the market price since there is heavy buying on the offer. GLTAL
• ZIOPHARM (ZIOP 11.26) target raised to $14 from $11 at Mizuho. Firm notes their DCF has been adjusted, adding the CAR/TCR program to their model. As details emerge they will adjust the discount rate/probability of success. They view the combination of ZIOP and MD Anderson in CAR/TCR as compelling, potentially differentiated but still early. Catalysts that help reiterate their Buy are 1) trial initiations in the CAR/TCR space, 2) potential data from one or more clinical programs by year-end, and 3) updates to the IL-12 program.
I like it and think it is going much higher as ZIOP announces partnerships in the coming days/weeks/months. Hold on to your shares fellas this could easily reach $20 in the next few weeks and double from there by mid 2015. GLTAL and GO ZIOP!!!
Market makers did their job today. Marked it up on light volume then did the usual dump to cash out some shares. Long term buy and hold for me so I will watch the games they play.
for $101 when the stock is trading at $113? What bizarro world are they living in?
So anything less than a 100% + increase in transactions is a disappointment? You are either an idiot or a short. In this case it is one in the same.
in the 116's and 117's? BABA will be a winner for years to come. Selling now is not a smart move.
to blow out the even the most optimistic numbers. GLTAL and go BABA!!!